This in turn renders IM-resistant GIST highly sensitive to dual targeting of FGFR and VEGFR pathways and potentiates the pro-apoptotic and anti-proliferative activities of the corresponding RTKi. The gene discussed is KDR; the disease is gastrointestinal stromal tumor.